Summary Significant numbers of mast cells have been demonstrated histologically around the periphery of the invasive rat mammary adenocarcinoma 13672NF. The number of mast cells at microfoci along the tumour:host tissue junction was significantly greater than that found in normal mammary tissues, and few mast cells were detected within the tumour itself. Mast cell degranulation, often associated with disruption and lysis of the connective tissue matrix, was a common feature in later stages of tumour proliferation. When soluble products derived from purified rat peritoneal mast cells were added to monolayer cultures of rat stromal fibroblasts or tumour cells they stimulated a significant increase in total collagenase production, and the mast cell products were also capable of activating the latent collagenases thus produced. Histological examination indicated that degradation of local collagenous matrix was a common feature of mast cell degranulation, an observation possibly explained by the release of mast cell enzymes and/or the potential of this cell to modulate the expression of collagenolytic activity by surrounding cells. These observations suggest that, at least in some tumours, mast cells contribute to the connective tissue breakdown commonly associated with tumour invasiveness and metastatic spread.
Since Erlich's (1879) first description of mast cells and their association with some neoplasms, numerous reports have appeared confirming their peripheral distribution around a variety of human and experimentally-induced tumours (Westphal, 1891; Sylven, 1945; Janes & McDonald, 1948; Fisher & Fisher, 1965; Hartveit, 1981; Farnoush & McKenzie, 1983 ,1984 . Mast cells are widely distributed in connective tissues and increased numbers have been reported in lesions of hypersensitivity and inflammatory granulomata. Although it has been suggested that mast cells are important in connective tissue disease (Smyth & Gum, 1958) and allergic-inflammatory disease , the functional significance of mast cells in tumour locations has remained speculative. Their ability to release heparin, histamine, proteinases, prostaglandins and various mediators and chemotactic factors by degranulation or carefully controlled exocytosis suggests that mast cells have important functions in cellular interactions and matrix degradation.
Because of our interest in the mechanisms of tumour invasion and metastasis, especially the cellular interactions involved in matrix degradation, we have focussed our attention on the tumour: host interface or 'invasion zone' as illustrated by the 13762NF rat mammary adenocarcinoma (Neri et al., 1982; Welch et al., 1983) . We report here our finding of numerous mast cells at the tumour periphery, an observation frequently associated with disruption or lysis of the local collagenous matrix. Mast cells have been shown to contain soluble products which stimulate fibroblasts to produce increased amounts of collagenase Pilarisetti et al., 1983; Atkins et al., 1985) , and mast cell products also have the ability to stimulate monocyte-macrophages to produce interleukin-1 (Yoffe et al., 1985) , a factor known to stimulate collagenase production by various mesenchymal cells (see Woolley et al., 1984) . Since mast cells apparently have the potential to modulate collagenolysis we have also examined and report here the in vitro effects of soluble mast cell products on the collagenolytic behaviour of rat stromal fibroblasts and tumour cells. Ltd., 1986 tained in alpha-modified minimum essential medium (AMEM) supplemented with 10% heat inactivated foetal calf serum, HIFCS, (Grand Island Biological Co., Grand Island, NY) as previously described (Neri & Nicolson, 1981; Neri et al., 1982) .
Materials and methods

Fibroblast cultures
Normal rat skin fibroblasts (NRS) were established from skin explants of syngeneic newborn rats. The subsequent fibroblast monolayers were grown in AMEM containing 10% HIFCS at 37°C in 5% CO2 and 95% humidified air.
In vivo studies Single cell suspensions of the tumour cells were prepared in Dulbecco's phosphate buffered saline, DPBS, (GIBCO). Tumour cells (5 x 105) were injected s.c. into the mammary fat pad of pathogenfree, female Fischer 344 rats, anaesthetised with methoxyflurane. Surgical resection of tumour specimens growing s.c. was carried out after 14, 18, 21, 25 and 32 days. At later stages the tumour cell mass varied in size and shape, but often measured more than 2 cm in its greatest dimension.
Histology
Tumour specimens with surrounding host issues were fixed for 2 h in 1% formaldehyde and 0.25% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) at 4°C, and rinsed in 0.15M cacodylate buffer prior to acetone dehydration. The specimens were embedded in JB-4 plastic (Polysciences, Warrington, PA) at 4°C, and 2,jm sections were cut with an LKB Historange microtome. Mast cells were stained for naphthol-AS-aminocaproate or naphthol-ASD-chloracetate esterase activity as described previously (Bromley et al., 1984; Bromley & Woolley, 1984) . All sections were counterstained with 0.25% azure II -0.25% methylene blue in 0.25% borax, and micrographs were taken on a Vickers M41 photoplan microscope using Kodak Panatomic-X film and green filter.
Mast cell products (MCP) Mast cells were collected from the peritoneal fluids of syngeneic rats and purified by Percoll density gradient centrifugation as described previously (Beelen & Walker, 1985) . After washing twice in DPBS, the purity was established by toluidine blue staining at >95% mast cells. The preparation was adjusted at 8 x 106 cells ml-1 in 1 M NaCl and extracted overnight at 4°C followed by sonication for 10 sec. After centrifugation at 16,000 rpm for 75 min at 4°C, the resulting supernatant was stored at -20°C as stock MCP.
Collagenase activity Fibroblasts and tumour cells were grown in multiwell trays (Coming, Corning, NY) containing AMEM-5%HIFCS. This medium was removed and replaced with AMEM-2%HIFCS with and without a supplement of 2.5% (v/v) MCP. Media was collected after 3 days, stored at -20°C, and adjusted to 50mM tris (pH 7.5), 10mM CaCl2 and 0.2 M NaCl prior to collagenase assay. For protein determination, a cell lysate was prepared from each well. Floating cells were collected from the centrifugation of the medium and DPBS, pooled and returned to their respective wells. Total cell densities were dissolved in 500 M1 0.1 N NaOH/well and protein concentrations were determined by the Bio-Rad Protein Assay (Bio-Rad, Rockville Centre,
Collagenase was assayed by measuring the release of soluble radioactive peptides from 30 pl 14C-glycine-labelled reconstituted gel of collagen fibrils (Dabbous et al., 1983a ) after 16h at 350C. One unit of collagenase degrades 1 jg collagen min 1 at 35°C and data is expressed as cumulative units per mg protein per 3 days of culture (Dabbous et al., 1983b) . Both fibroblast and tumour cell cultures produced latent collagenase which was activated by conventional trypsin treatment -50,jgml-1 for 12 min followed by 125jgml-P of soybean trypsin inhibitor. Activation of latent collagenase preparations by mast cell products was performed at 340C for 10min or 4h, after which an inhibitor cocktail of 1 mg ml-1 soybean tryspin inhibitor, 10 mM Nethyl maleimide and 1 mM phenyl methyl sulphonyl fluoride was added.
All assays were performed in triplicate and represent the mean value + s.e. Control assays included: (1) buffer alone which routinely released no more than 3% solubilisation of total counts available, (2) mast cell products at the test dilution which released approximately 6% of total counts, and (3) trypsin (5 jg ml-1) which released no more than 8% of total counts thereby confirming the native integrity of the collagen substrate. The enzyme activity released by both fibroblast and tumour cell cultures was inhibited by the metal chelator ethylene diamine tetra-acetic acid, and at 25°C produced the typical 3:4 cleavage product of type I collagen monomers as described previously (Dabbous et al., 1977; Woolley et al., 1984) .
Results
Mast cells were found to be randomly dispersed in the connective tissue and between fat deposits of normal rat mammary tissue and most frequently around small blood vessels. In contrast the tumour specimens showed a significant increase in the numbers of mast cells which were predominantly located in microfoci at the tumour:host interface or 'invasion zone', and within connective stromal tissue adjacent to the tumour (Figure 1 ). Mast cell degranulation was often observed at these sites and was invariably associated with localised matrix degradation (Figure 2 ), especially at later stages of tumour growth.
Mast cells were infrequent in the main mass of tumour cells up to day 25, and no sign of mast cell granules was found within the tumour despite the use of highly specific histochemical staining techniques. However, mast cells were commonly observed within the tumour cell mass after 32 days of tumour growth and nearly all appeared intact, suggesting that the presence of tumour cells per se did not induce degranulation. Additionally, intact mast cells were frequently observed alongside fibroblasts in the connective tissue stroma remote from tumour cells. Thus the factors that bring about local mast cell degranulation at some tumour:host junctions remain uncertain.
The enzymatic mechanism of localised lysis of connective tissue associated with mast cell degranulation has been examined in vitro by studying the effects of mast cell components on the collageno- lytic expression of cultured fibroblasts and tumour cells. Exposure of these cells to soluble mast cell products (MCP) produced a 7.9 and 12-fold increase in total collagenase production for fibroblast and tumour cell cultures respectively (Table I) . MCP itself had no detectable collagenase activity. Latent collagenase preparations derived from cultures of MTLn3 tumour cells or from rat stromal fibroblasts was effectively activated by MCP (Table II) . Moreover, the level of activation produced by MCP was equivalent to that produced by optimal trypsin treatments. Thus soluble mast cell products not only had the capacity to stimulate collagenase production by fibroblast and tumour cells but also had the ability to activate the released latent enzyme.
Discussion
Aggregation of mast cells at the periphery of various tumours has long been recognised but their functional significance at the tumour:host junction remains unclear. Several studies have suggested a protective role for mast cells against tumours. For instance mouse mast cells were reported to be cytotoxic to mouse artd rat fibrosarcomas (Farram & Nelson, 1980) and the growth of pulmonary metastases of B16 melanoma was observed in mast cell-free mice but not in normal mice ((Schitteck et al., 1985) . Similarly an inverse correlation between tumour incidence and tissue histamine levels was reported for fibrosarcomas and Lewis lung carcinomas (Burtin et al., 1985) . The importance of (Lewis & Austin, 1981; Parwaresch et al., 1985) , but in direct contrast to the reports of a protective role against tumours some investigators have stressed an association between mast cells and rapid tumour growth (Csaba et al., 1961; Farnoush & McKenzie, 1983) . Both heparin and histamine have been reported to have mitogenic properties (Roche, 1985; Norrby, 1985; Norrby & Enestrom, 1985) and Hartveit (1981) reported that mast cell degranulation in human breast carcinomas was associated with areas of infiltrative growth. Such diverse findings suggest that a unitary explanation for the functional significance of mast cells in tumour cell invasion is unlikely. However, the 13762NF rat mammary adenocarcinoma has several histological similarities to human breast carcinomas (Hartveit, 1981; Hartveit & Sandstad, 1982; Hartveit et al., 1984) and the studies reported here may therefore be more relevant to the pathology of these neoplasms.
Mast cell degranulation in the rat, elicited by compound 48/80, was reported to induce local proliferation of fibroblasts and mesothelial cells with depletion of extracellular matrix as judged by ultrastructural studies (Norrby & Enestrom, 1984) . Similarly in the present study at the later stages of tumour growth an increasing frequency of mast cell degranulation was associated with connective tissue lysis and, significantly, the latter was never observed around intact mast cells. The extent of degranulation was variable, not only between different tumour specimens but also at different locations in the same tumour. At present the stimulus for degranulation has not been identified, (Lagunoff, 1968; Birkedal-Hansen et al., 1976; Keiser, 1980; Metcalfe & kaliner, 1981; Schwartz, 1983) and the tryptase of human mast cells, which is apparently resistant to plasma antiproteinases (Schwartz et al., 1981) , may contribute to fibrinolysis (Schwartz et al., 1985) , matrix destruction and the activation of cascade mechanisms. We have been unable to demonstrate detectable levels of a true collagenase in rat MCP, although the recent identification of human mast cell elastase (Meier et al., 1985) could conceivably contribute collagenolytic activity. However, perhaps of greater relevance to in vivo collagenolysis is the finding that mast cell products significantly stimulated collagenase production by stromal fibroblast and tumour cell cultures, an observation previously reported for synovial fibroblasts . As yet the stimulatory factor has not been identified, but the response of tumour cell lines to mast-cell mediated stimulation of collagenolysis appears to be related to the metastatic potential of the tumour cell (Dabbous et al., 1986) . The MCP preparations used in this study also proved effective activators for latent collagenases derived from fibroblast and tumour cells, presumably mediated via mast cell proteases as described previously (Birkedal-Hansen et al., 1976) . Thus the potential for MCP to stimulate latent collagenase production by surrounding fibroblasts or tumour cells, and subsequently to activate the released precursor, provides one effective mechanism for the generation of local collagenolytic activity. Another pathway is suggested by the report that macrophages are stimulated by MCP, probably heparin, to produce increased amounts of interleukin-1 (Yoffe et al., 1985) , a factor known to stimulate collagenase production by fibroblasts and tumour cells (Henry et al., 1983) .
Many studies have examined the role of collagenolytic enzymes in tumour invasion and metastatic spread (for reviews see Woolley et al., 1980; Liotta et al., 1982; and recently several investigations have emphasised the importance of tumour:host cell interactions in connective tissue degradation (Tarin, 1976; Dabbous et al., 1977 Dabbous et al., ,1983a Biswas, 1982; Henry et al., 1983) . The tumour: host interface or 'invasion zone' (Strauli, 1980) of many invasive tumours is variable with regard to the type and relative numbers of host cells. Previous immunolocalisation studies have demonstrated that collagenase production at the tumour edge is often microenvironmental in nature, but the cellular origin of the enzyme may depend to some extent on the type or tissue location of the invasive tumour (Woolley, 1982; Woolley & Grafton, 1980; Barsky et al., 1983) . Further enzyme localisation studies in conjunction with the identification of specific host cells should help to elucidate which cellular interactions are involved in generating local collagenolysis in vivo. However, at present our histological findings suggest that degradation of local collagenous matrix is a common feature of mast cell degranulation, an observation possibly related to the release of mast cell enzymes and/or the potential of this cell to modulate the expression of collagenolytic activity by surrounding cells.
